April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
Foghorn Therapeutics (FHTX) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: May 15, 2025 (21:59)
Sector: HealthcareThe share price of Foghorn Therapeutics Inc. (FHTX) now
Are you interested in Foghorn Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Foghorn Therapeutics stock price in 2025, 2026, 2027. How much will one Foghorn Therapeutics share be worth in 2025 - 2027?
When should I take profit in Foghorn Therapeutics stock? When should I record a loss on Foghorn Therapeutics stock? What are analysts' forecasts for Foghorn Therapeutics stock? What is the future of Foghorn Therapeutics stock? We forecast Foghorn Therapeutics stock performance using neural networks based on historical data on Foghorn Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Foghorn Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Foghorn Therapeutics shares. This happens once a day.
Historical and forecast chart of Foghorn Therapeutics stock
The chart below shows the historical price of Foghorn Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Foghorn Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Foghorn Therapeutics Inc. focuses on the discovery and development of drugs targeting genetically determined addictions in the chromatin regulatory system. The Company’s gene traffic management platform enables it to identify, validate and potentially use drug targets in the chromatin regulatory system. It is initially focused on oncology. The company is developing FHD-286, a selective allosteric ATPase inhibitor, and FHD-609, a protein breaker, for the treatment of hematologic cancers and solid tumors. FHD-286 is an allosteric and orally available, small molecule, enzymatic inhibitor of BRG1 and BRM, which is initially being developed for the treatment of acute myeloid leukemia (AML) and uveal melanoma. FHD-609 is an intravenous, small molecule protein breaker BRD9. The company is also developing complementary programs for large populations, which include selective BRM and selective ARID1B modulators.
Foghorn Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 17 | 4.30 | 4.19 | 4.34 | 3.49 |
| May 18 | 4.28 | 4.18 | 4.35 | 4.02 |
| May 19 | 4.35 | 4.29 | 4.42 | 3.17 |
| May 20 | 4.22 | 4.15 | 4.27 | 2.89 |
| May 21 | 4.34 | 4.30 | 4.46 | 3.67 |
| May 22 | 4.41 | 4.30 | 4.46 | 3.78 |
| May 23 | 4.42 | 4.35 | 4.50 | 3.45 |
| May 24 | 4.39 | 4.35 | 4.50 | 3.39 |
| May 25 | 4.40 | 4.29 | 4.51 | 5.17 |
| May 26 | 4.39 | 4.27 | 4.44 | 4.07 |
| May 27 | 4.42 | 4.33 | 4.46 | 3.07 |
| May 28 | 4.55 | 4.51 | 4.65 | 3.19 |
| May 29 | 4.54 | 4.41 | 4.59 | 4.08 |
| May 30 | 4.58 | 4.52 | 4.73 | 4.46 |
| May 31 | 4.52 | 4.38 | 4.65 | 6.20 |
| Jun 01 | 4.54 | 4.45 | 4.62 | 3.71 |
| Jun 02 | 4.68 | 4.58 | 4.81 | 5.03 |
| Jun 03 | 4.70 | 4.60 | 4.76 | 3.35 |
| Jun 04 | 4.68 | 4.54 | 4.80 | 5.81 |
| Jun 05 | 4.72 | 4.62 | 4.85 | 5.11 |
| Jun 06 | 4.73 | 4.68 | 4.77 | 2.11 |
| Jun 07 | 4.67 | 4.53 | 4.72 | 4.13 |
| Jun 08 | 4.67 | 4.61 | 4.75 | 3.00 |
| Jun 09 | 4.59 | 4.49 | 4.71 | 4.78 |
| Jun 10 | 4.51 | 4.45 | 4.56 | 2.44 |
| Jun 11 | 4.49 | 4.35 | 4.57 | 4.87 |
| Jun 12 | 4.31 | 4.22 | 4.43 | 4.90 |
| Jun 13 | 4.37 | 4.28 | 4.46 | 4.37 |
| Jun 14 | 4.45 | 4.33 | 4.51 | 4.27 |
| Jun 15 | 4.51 | 4.44 | 4.64 | 4.35 |
Foghorn Therapeutics Daily Price Targets
Foghorn Therapeutics Stock Forecast 05-17-2025.
Forecast target price for 05-17-2025: $4.30.
Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.373%.
Pessimistic target level: 4.19
Optimistic target level: 4.34
Foghorn Therapeutics Stock Forecast 05-18-2025.
Forecast target price for 05-18-2025: $4.28.
Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.864%.
Pessimistic target level: 4.18
Optimistic target level: 4.35
Foghorn Therapeutics Stock Forecast 05-19-2025.
Forecast target price for 05-19-2025: $4.35.
Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.071%.
Pessimistic target level: 4.29
Optimistic target level: 4.42
Foghorn Therapeutics Stock Forecast 05-20-2025.
Forecast target price for 05-20-2025: $4.22.
Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 2.806%.
Pessimistic target level: 4.15
Optimistic target level: 4.27
Foghorn Therapeutics Stock Forecast 05-21-2025.
Forecast target price for 05-21-2025: $4.34.
Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.540%.
Pessimistic target level: 4.30
Optimistic target level: 4.46
Foghorn Therapeutics Stock Forecast 05-22-2025.
Forecast target price for 05-22-2025: $4.41.
Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.644%.
Pessimistic target level: 4.30
Optimistic target level: 4.46
FHTX (FHTX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 4.83 | 3.97 | 6.29 | 36.85 |
| Jul. | 6.17 | 5.36 | 7.10 | 24.51 |
| Aug. | 6.26 | 4.99 | 6.94 | 27.99 |
| Sep. | 4.64 | 3.46 | 5.77 | 40.04 |
| Oct. | 4.66 | 3.81 | 6.20 | 38.55 |
| Nov. | 3.65 | 3.16 | 4.70 | 32.87 |
| Dec. | 4.56 | 4.14 | 6.07 | 31.83 |
Foghorn Therapeutics forecast for this year
Foghorn Therapeutics Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $4.83168. Pessimistic: $3.97. Optimistic: $6.29
Foghorn Therapeutics Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $6.1715. Pessimistic: $5.36. Optimistic: $7.10
Foghorn Therapeutics Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $6.25852. Pessimistic: $4.99. Optimistic: $6.94
Foghorn Therapeutics Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $4.6407. Pessimistic: $3.46. Optimistic: $5.77
Foghorn Therapeutics Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $4.66251. Pessimistic: $3.81. Optimistic: $6.20
Foghorn Therapeutics Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $3.65447. Pessimistic: $3.16. Optimistic: $4.70
Foghorn Therapeutics Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $4.5648. Pessimistic: $4.14. Optimistic: $6.07
Foghorn Therapeutics (FHTX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.16 | 3.08 | 5.19 | 40.64 |
| Feb | 4.04 | 3.51 | 5.56 | 36.89 |
| Mar | 3.36 | 2.71 | 3.86 | 29.82 |
| Apr | 3.85 | 3.36 | 4.79 | 29.84 |
| May | 2.54 | 2.16 | 3.36 | 35.62 |
| Jun | 2.74 | 2.41 | 3.25 | 25.72 |
| Jul | 2.76 | 2.18 | 3.42 | 36.40 |
| Aug | 3.71 | 2.71 | 4.32 | 37.13 |
| Sep | 3.95 | 3.08 | 4.71 | 34.68 |
| Oct | 3.27 | 2.68 | 4.16 | 35.46 |
| Nov | 2.85 | 1.85 | 3.59 | 48.55 |
| Dec | 3.74 | 2.63 | 4.70 | 44.07 |
Foghorn Therapeutics (FHTX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 3.75 | 3.17 | 4.30 | 26.25 |
| Feb | 2.29 | 1.55 | 2.60 | 40.54 |
| Mar | 2.22 | 1.48 | 2.83 | 47.64 |
| Apr | 1.40 | 1.02 | 1.73 | 40.95 |
| May | 1.31 | 0.95 | 1.47 | 35.60 |
| Jun | 1.70 | 1.12 | 1.98 | 43.41 |
| Jul | 2.47 | 1.70 | 3.16 | 46.19 |
| Aug | 3.04 | 2.45 | 3.74 | 34.38 |
| Sep | 1.82 | 1.27 | 2.17 | 41.54 |
| Oct | 2.12 | 1.54 | 2.44 | 37.03 |
| Nov | 2.57 | 2.31 | 3.21 | 28.22 |
| Dec | 2.61 | 2.03 | 3.25 | 37.39 |
Foghorn Therapeutics information and performance
500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, US
Market capitalization of the Foghorn Therapeutics Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of FHTX shares in the company outstanding by the market price of one share.
EBITDA of Foghorn Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Foghorn Therapeutics Stock)
Should I Buy Foghorn Therapeutics Shares in 2025 year?
Does Foghorn Therapeutics pay dividends?
Which economic sector do Foghorn Therapeutics's shares belong to?
Which other securities belong to the same sector as Foghorn Therapeutics's shares?
